Literature DB >> 27349276

FYN promotes breast cancer progression through epithelial-mesenchymal transition.

Ye-Gong Xie1, Yue Yu1, Li-Kun Hou1, Xin Wang1, Bin Zhang1, Xu-Chen Cao1.   

Abstract

FYN, one of the members of the Src family of kinases (SFKs), has been reported to be overexpressed in various types of cancers and correlated with cell motility and proliferation. However, the mechanism is still unclear. In the present study, we found that FYN was overexpressed in breast cancer and overexpression of FYN promoted cell proliferation, migration and invasion in the MCF10A cells, whereas depletion of FYN suppressed cell proliferation, migration and invasion in the MDA-MB-231 cells. Moreover, FYN upregulated the expression of mesenchymal markers and epithelial-mesenchymal transition (EMT)-related transcription factors, and downregulated the expression of epithelial markers, suggesting that FYN induces EMT in breast cancer cells. Furthermore, FYN was transcriptionally regulated by FOXO1 and mediated FGF2-induced EMT through both the PI3K/AKT and ERK/MAPK pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27349276     DOI: 10.3892/or.2016.4894

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

1.  The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data.

Authors:  Yanshan Ge; Zhengxi He; Yanqi Xiang; Dawei Wang; Yuping Yang; Jian Qiu; Yanhong Zhou
Journal:  Mol Biol Rep       Date:  2019-03-04       Impact factor: 2.316

2.  Fusion of the COL1A1 and FYN Genes in Epithelioid Osteoblastoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Ingvild Lobmaier; Marius Lund-Iversen; Kristin Andersen; Arild Holth; Bodil Bjerkehagen; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

3.  Fyn and Lyn gene polymorphisms impact the risk of thyroid cancer.

Authors:  Asif Nisar; Mahmood Akhtar Kayani; Wajiha Nasir; Azhar Mehmood; Malik Waqar Ahmed; Aamir Parvez; Ishrat Mahjabeen
Journal:  Mol Genet Genomics       Date:  2022-09-04       Impact factor: 2.980

4.  DPYSL2 interacts with JAK1 to mediate breast cancer cell migration.

Authors:  Areej Abu Rmaileh; Balakrishnan Solaimuthu; Anees Khatib; Shirel Lavi; Mayur Tanna; Arata Hayashi; Michal Ben Yosef; Michal Lichtenstein; Nir Pillar; Yoav D Shaul
Journal:  J Cell Biol       Date:  2022-05-16       Impact factor: 8.077

5.  Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYN.

Authors:  Carmen Veith; Milena Hristova; Karamatullah Danyal; Aida Habibovic; Christopher M Dustin; John E McDonough; Bart M Vanaudenaerde; Michael Kreuter; Marc A Schneider; Nicolas Kahn; Frederik J van Schooten; Agnes W Boots; Albert van der Vliet
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-12-16       Impact factor: 5.464

6.  Manganese-12 acetate suppresses the migration, invasion, and epithelial-mesenchymal transition by inhibiting Wnt/β-catenin and PI3K/AKT signaling pathways in breast cancer cells.

Authors:  Hongping Ju; Yongxia Li; Xiqian Xing; Xisong Miao; Yunping Feng; Yunhui Ren; Jing Qin; Dian Liu; Zihao Chen; Zhaoyu Yang
Journal:  Thorac Cancer       Date:  2018-01-08       Impact factor: 3.500

7.  Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.

Authors:  Tao Pan; Fang Zhang; Fakai Li; Xingchun Gao; Zhikui Li; Xia Li; Xinling Ren
Journal:  Oncol Rep       Date:  2020-07-09       Impact factor: 3.906

8.  Comprehensive Proteomic Characterization Reveals Subclass-Specific Molecular Aberrations within Triple-negative Breast Cancer.

Authors:  Max Kosok; Asfa Alli-Shaik; Boon Huat Bay; Jayantha Gunaratne
Journal:  iScience       Date:  2020-01-28

9.  Genetic interactions between ANLN and KDR are prognostic for breast cancer survival.

Authors:  Xiaofeng Dai; Xiao Chen; Olivier Hakizimana; Yi Mei
Journal:  Oncol Rep       Date:  2019-09-24       Impact factor: 3.906

10.  TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.

Authors:  María Paz Saldías; Diego Maureira; Octavio Orellana-Serradell; Ian Silva; Boris Lavanderos; Pablo Cruz; Camila Torres; Mónica Cáceres; Oscar Cerda
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.